Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna Inc
(NQ:
MRNA
)
43.66
+2.55 (+6.20%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
99
100
Next >
Unpacking the Latest Options Trading Trends in Moderna
July 05, 2024
Via
Benzinga
3 Biotech Stocks to Sell in July Before They Crash & Burn
July 05, 2024
While biotech stocks have potential to provide high returns, they are often overly dependent on drug approvals. Sell these before its too late
Via
InvestorPlace
3 Biotech Stocks Turning DNA Dreams Into Dollars
July 05, 2024
Investors should consider buying into one of the future avenues of medicine by investing in these three BNA biotech stocks.
Via
InvestorPlace
AI Has 'The Hallmarks Of An Inflating Bubble,' Warns Veteran Wall Street Investor
July 04, 2024
Word to the wise: Ed Yardeni, in a July 4 note, warns his clients: "Too much capital can end even the best of parties."
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Here's How Much $1000 Invested In Moderna 5 Years Ago Would Be Worth Today
July 04, 2024
Via
Benzinga
What's Going On With Moderna Stock Wednesday
July 03, 2024
Moderna announced a $176 million award for the development of an mRNA-based Influenza vaccine.
Via
Benzinga
What's Going On With Moderna Stock Friday?
June 28, 2024
Moderna's RSV vaccine, mRNA-1345, is designed to protect adults aged 60 and older from respiratory disease caused by the RSV infection.
Via
Benzinga
In-Depth Examination Of 10 Analyst Recommendations For Moderna
June 27, 2024
Via
Benzinga
Moderna's Options: A Look at What the Big Money is Thinking
June 24, 2024
Via
Benzinga
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
July 02, 2024
The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame during the COVID-19 pandemic. The beauty of mRNA technology is that it opens...
Via
Benzinga
Exposures
COVID-19
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents
July 02, 2024
Pfizer and Moderna continue their legal battle over COVID-19 vaccine patents following a mixed ruling by London's High Court, with potential appeals on the horizon and significant financial stakes...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
July 02, 2024
The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.
Via
MarketBeat
Topics
ETFs
Exposures
COVID-19
Amid Rapidly Rising Bird Flu Cases, Moderna Lands $176M Worth US Government Contract For Vaccine
July 02, 2024
The funds will be utilized to finalize the late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $900 Today
June 21, 2024
Via
Benzinga
Market Whales and Their Recent Bets on MRNA Options
June 20, 2024
Via
Benzinga
Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
July 02, 2024
Via
ACCESSWIRE
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
July 01, 2024
There are more marketplace opportunities than just AI which is why these stocks that are outperforming Nvidia have done so well.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Moderna And Walgreens Boots Alliance Were Among The 10 Biggest Large Cap Losers Last Week (June 23 - June 29): Are These In Your Portfolio?
June 30, 2024
10 worst performing large-cap stocks last week: Walgreens, Floor & Decor, Moderna, Birkenstock, BeiGene, Pool Corp, JD.com, Ecopetrol, International Paper, Micron.
Via
Benzinga
Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet
June 28, 2024
Undiscovered biotech stocks can be risky but rewarding, especially when it involves mid-cap stocks with promise and no profit.
Via
InvestorPlace
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)
June 28, 2024
Via
ACCESSWIRE
Silver Prices Fell To A 6-Week Low
June 27, 2024
Silver prices held below $29 an ounce, near a six-week low, and were pressured by a strong dollar and Treasury bond yields after hawkish remarks from a Federal Reserve official.
Via
Talk Markets
Topics
Bonds
Economy
Exposures
Debt Markets
Interest Rates
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK
June 27, 2024
The CDC's ACIP recommends RSV vaccines for adults 75+, and for those 60-74 with chronic conditions. GSK's Arexvy is approved for adults 50-59 at risk. A decision on adults 50-59 is pending further...
Via
Benzinga
2 Stocks Down More Than 30% to Buy Right Now
June 27, 2024
These stocks have suffered as the demand for their biggest product -- the coronavirus vaccine -- waned.
Via
The Motley Fool
Exposures
COVID-19
10 Health Care Stocks Whale Activity In Today's Session
June 26, 2024
Via
Benzinga
Dow Nearly 100 Points Lower Amid Slumping Home Sales
June 26, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Why Is Moderna Stock Trading Lower On Wednesday?
June 26, 2024
The CDC's Advisory Committee on Immunization Practices is set to discuss recommendations for RSV, influenza, and COVID-19 vaccines. Moderna's data shows vaccine efficacy drops to 50% after 18 months in...
Via
Benzinga
Exposures
COVID-19
Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots
June 26, 2024
After 18 months, Moderna's RSV vaccine proved about 50% effective against lower respiratory tract disease.
Via
Investor's Business Daily
Beating Cancer Is Still An Everything-But-Easy Challenge That Pharmaceutical Companies Cannot Solve Overnight
June 26, 2024
On Tuesday, Merck Group revealed an unexpected decision to end a Phase III trial of its cancer drug Xevinapant. This move threatens to undermine confidence the research abilities of the Darmstadt,...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 25, 2024
Via
Benzinga
What's Going On With Eli Lilly Stock On Tuesday?
June 25, 2024
Eli Lilly collaborates with Microsoft-backed OpenAI to leverage generative AI for developing novel antimicrobials targeting drug-resistant pathogens. This partnership supports Lilly's commitment to...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.